
Intus Bio is a microbiome discovery and understanding company leveraging its proprietary Titan-1™ platform, which offers a generation ahead approach to studying the microbiome, surpassing traditional 16S and shotgun metagenomics. The platform is built on a patented assay and proprietary AI tools, enabling high-resolution, high-throughput, and database-independent analysis that delivers strain-level data for known and unknown strains. This unique capability allows for the identification and tracking of fundamental microbiome units (strains), which is crucial for actionable insights in drug development, biomarker discovery, and patient care across various applications including gut function and wound management. Intus Bio controls the entire 'sample to solution' process, ensuring quality and accuracy, and is working with pharmaceutical, academic, and commercial lab partners.

Intus Bio is a microbiome discovery and understanding company leveraging its proprietary Titan-1™ platform, which offers a generation ahead approach to studying the microbiome, surpassing traditional 16S and shotgun metagenomics. The platform is built on a patented assay and proprietary AI tools, enabling high-resolution, high-throughput, and database-independent analysis that delivers strain-level data for known and unknown strains. This unique capability allows for the identification and tracking of fundamental microbiome units (strains), which is crucial for actionable insights in drug development, biomarker discovery, and patient care across various applications including gut function and wound management. Intus Bio controls the entire 'sample to solution' process, ensuring quality and accuracy, and is working with pharmaceutical, academic, and commercial lab partners.